AOM International Group Company Limited (AOM International; HKEX: 00381) disclosed that it entered into a Memorandum of Understanding on 22 September 2026 with Hong Kong-incorporated Winutri Life Group Limited to establish a jointly owned limited-liability company in Hong Kong.
The prospective joint venture will integrate Winutri Life’s anti-aging consumer products, AI smart rings and SaaS-based health data operations with AOM International’s existing toy, natural resources and health-related businesses. Operational management, including supply chain, distribution and data operations, will be led by Winutri Life.
Key terms include: • Exclusivity: Both parties commit to a 60-day exclusivity period from the signing date, during which they will not pursue similar arrangements with third parties. • Due diligence: AOM International is entitled to conduct legal and asset due diligence on Winutri Life and its subsidiaries within the exclusivity window. • Formal agreement: The parties target execution of a definitive joint-venture agreement within 60 days, subject to possible extension by mutual consent. • Legal effect: The MOU is non-binding on commercial terms such as consideration and capital contributions but is binding on confidentiality, exclusivity, due diligence and termination clauses.
Winutri Life positions itself as a “health data asset operator,” utilising technology originating from Harvard University’s Aging Biology Research Institute. Its model combines physical anti-aging products, AI-driven smart rings and integrated SaaS solutions that convert continuous biometrics—temperature, blood oxygen and heart rate—into monetisable digital assets. The company already operates provincial branches in mainland China and is expanding into Singapore, Malaysia, Thailand and selected Western markets. Its AI rings have reached mass production, and its SaaS platform and data compliance framework (GDPR, HIPAA) are operational.
AOM International views the planned venture as aligned with its strategy to broaden revenue streams and capture growth opportunities in the “active health and aging” sector, potentially enhancing shareholder value.
If completed, the transaction may constitute a notifiable event under Hong Kong’s Listing Rules. The company will issue further announcements as required. There is no certainty the joint venture will proceed, and investors are advised to exercise caution when dealing in AOM International’s shares.
Comments